Oncology & Cancer

Scientists trial new way to boost CAR T-cell therapy

Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that 'reboots' a treatment for some people with blood cancer whose cancer starts to come back.

Immunology

Future of immunotherapy could be 'off-the-shelf' treatments

In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" ...

Vaccination

Why COVID-19 vaccine research remains critical

While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight ...

Diseases, Conditions, Syndromes

For an effective COVID vaccine, look beyond antibodies to T-cells

More than 100 companies have rushed into vaccine development against COVID-19 as the U.S. government pushes for a vaccine rollout at "warp speed"—possibly by the end of the year—but the bar set for an effective, long-lasting ...

page 2 from 5